DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. The study was funded by Medtronic, Inc. and Korea United Pharm.

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

DAIC

NOVEMBER 8, 2024

PTA+DCB, P Key findings include: · One-year primary patency (freedom from both clinically driven target lesion revascularization and duplex ultrasound-derived restenosis) did not differ between groups, despite the significant difference in baseline calcification. · DA+DCB versus 5.9% versus 21.1%, P =0.014). 3 · One-year rates of TLR (16.6%

Stent 52

Stent Stents Angioplasty Peripheral Arterial Disease 52

DAIC

JANUARY 9, 2024

The roundtable provided a unique opportunity to identify knowledge gaps and discuss how IVUS can enhance our understanding and treatment of peripheral arterial and deep venous pathology." They also emphasized the need for further research and evidence to support the integration of IVUS into routine clinical practice.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Ultrasound Angioplasty Patient Care 105

Dr. Anish Koka

JULY 23, 2023

Most have gotten used to egregiously bad coverage of current events that fills the pages of today’s New York Times, but even by their now very low standards a recent telling of a story about peripheral artery disease was very bad. 12.27.2016. Mr. Rosenberg meets Dr. Dormu.

Vascular Care 52

Vascular Care Outpatient Peripheral Arterial Disease Stent 52